Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 24. Juli 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9013  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180250  
   
Rapidly progressive synchronous multifocal gastrointestinal stenoses in bladder cancer: diagnostic challenges and clinical implications.
Int Cancer Conf J
Yasuda K, Tsujino M, Yamasaki H, Kurahashi Y, Nakagawa M, Kishikawa H, Yoshida T.
PMID: 42491143 [PubMed]


PSMA PET/CT improves precision diagnosis, treatment, and clinical decision-making in prostate cancer.
Am J Transl Res
Sun X.
PMID: 42491025 [PubMed]


Image-guided moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
J Radiat Res
Iizumi T, Ishikawa H, Sekino Y, Murakami M, Tanaka K, Takizawa D, Makishima H, Mori Y, Kamizawa S, Mizumoto M, Okumura T, Suzuki H, Nishiyama H, Sakurai H.
PMID: 42490752 [PubMed - as supplied by publisher]


Efficacy and limitations of diffusion-weighted imaging with background suppression-based whole-body magnetic resonance imaging in high-risk prostate cancer staging: A retrospective study.
PLoS One
Nakajima N, Kazama T, Takahara T, Oda K, Ogawa T, Aoki M, Ono S, Naruse J, Takahashi K, Yuzuriha S, Otaki T, Umemoto T, Kawakami M, Kawamura Y, Shoji S.
PMID: 42490591 [PubMed - indexed for MEDLINE]


Editorial Comment: Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee.
Int Braz J Urol
Favorito LA.
PMID: 42490510 [PubMed - in process]


Head-to-head comparison of (99m)Tc-MIP-1404 CZT SPECT/CT and (68)Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study.
EJNMMI Res
Saudi A, Ståhlgren M, Takhar P, Norberg P, Holmbom M, Dahl J, Afshar M, Albert-García I, Forsberg J, Ressner M, Elgland M, Sanchez-Rodriguez V, Aljabery F, Ochoa-Figueroa M.
PMID: 42489957 [PubMed]


Towards implementation of precision medicine biomarkers in early detection and prognostication of prostate cancer.
Cancer Metastasis Rev
Yee A, Smith J, Kumar R, Sali A, Rodger EJ, Chatterjee A.
PMID: 42489928 [PubMed - indexed for MEDLINE]


Development of a prostate cancer survivorship care toolkit for Black men with clinical and contextual tailoring.
Support Care Cancer
Ashing K, Willis F, Williams C, Morrison J, McCall J, Song G, Bedell F, Moore C, Cobran E, Ngufor C, Bonner T, Dagne G, Merriweather A, Oliver J, Kaninjing E, Oladapo R, Dronca R, Odedina F.
PMID: 42489746 [PubMed - indexed for MEDLINE]


Cancer Risk After Simultaneous Pancreas-Kidney Transplantation Compared With Kidney Transplant Alone: A Propensity-Matched Cohort Study.
Clin Transplant
Balloura MA, Mawaldi M, Johnson B, Ovincy C, Fontanez NC, Ingram D, Me HM, Leeaphorn N, Attieh RM.
PMID: 42489648 [PubMed - indexed for MEDLINE]


Intense Focal Peripheral Uptake Pattern on 18F-PET/PSMA as a Predictor of Histological Upgrading in Prostate Cancer.
Prostate
González-Martínez CA, Alcacio-Mendoza JA, Hernández-Ramírez R, Lagos-Beitz HE, Tena-González-Méndez G, Gabilondo-Navarro F, Castillejos-Molina RA.
PMID: 42489410 [PubMed - as supplied by publisher]


Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection.
MedComm (2020)
Xiong X, Zhu W, Huang W, Zhang S, Deng Q, Yang J, Xu H, Wei Q, Yang L.
PMID: 42488705 [PubMed]


Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis.
Front Immunol
Qin J, Zhou H, Li X, Yin H, Deng H, Luo Y, Chen Y, Yin Y, Zhou R, Zhan N, Zheng Y, Zhang T, He W.
PMID: 42488678 [PubMed - indexed for MEDLINE]


Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment.
Front Immunol
Dong Y, Su Y.
PMID: 42488630 [PubMed - indexed for MEDLINE]


Cellular plasticity and tumor ecosystem dynamics in prostate cancer: insights from single-cell and spatial transcriptomics.
Am J Clin Exp Urol
Watanabe R, Chu T, Miura N, Kikugawa T, Nelson PS, Saika T.
PMID: 42488354 [PubMed]


Threading the Needle in Bladder Cancer: A Narrative Review of the Emerging Role of Integrative Oncology in Treatment-Related Adverse Events in the Era of Immunotherapy and Antibody-Drug Conjugates.
Cureus
Niknafs AM, Damron LF, Baclig NV, Iliopoulos M, Drakaki A.
PMID: 42488263 [PubMed]


External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.
Int J Urol
Nakano Y, Miyamoto S, Goto K, Yukihiro K, Tasaka S, Nomura N, Okazaki M, Shikuma H, Hatayama T, Iwane K, Tasaka R, Kohada Y, Takemoto K, Naito M, Kobatake K, Sekino Y, Kitano H, Goriki A, Hieda K, Hinata N.
PMID: 42487496 [PubMed - indexed for MEDLINE]


Prognostic value of platelet-to-lymphocyte ratio in bladder cancer: a systematic review and meta-analysis.
Clin Transl Oncol
Pan M, Tao T, Peng J, Zhang Y, Kong D, Chen K, Wu H, Yang B, Gong H.
PMID: 42487089 [PubMed - as supplied by publisher]


Development and internal validation of a biparametric MRI-based nomogram for predicting extraprostatic extension in patients undergoing robot-assisted radical prostatectomy.
J Robot Surg
Yamane H, Morizane S, Hasegawa A, Yasukawa R, Tamura J, Omatsu R, Shimizu R, Teraoka S, Nishikawa R, Kimura Y, Hikita K, Takenaka A.
PMID: 42486920 [PubMed - indexed for MEDLINE]


BCG at Home: A First-in-kind Trial of Home-based Intravesical Bacillus Calmette-Guérin Delivery for High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Focus
Lee DJ, Williams C, Soefje S, Flynn D, Kessler S, Northern L, Yoo J, Radovanovich A, Kim D, Cappozzi D, Obare A, Stambakio H, Guzzo T, Bivalacqua TJ.
PMID: 42486771 [PubMed - as supplied by publisher]


Re: Comprehensive Genome-wide Association Study Into Multiple Recurrence and Progression Risk in Non-muscle-invasive Bladder Cancer.
Eur Urol
Lazzeri M, Hurle R, Lughezzani G, Buffi NM, Casale P.
PMID: 42486741 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 180250    Seite 1 von 9013  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1